Detailed Information on Publication Record
2016
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
BRYJA, Vítězslav, Markéta KAUCKÁ, Karla PLEVOVÁ, Šárka PAVLOVÁ, Šárka POSPÍŠILOVÁ et. al.Basic information
Original name
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Authors
BRYJA, Vítězslav (203 Czech Republic, guarantor, belonging to the institution), Markéta KAUCKÁ (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Alois KOZUBÍK (203 Czech Republic, belonging to the institution)
Edition
Number: CA 2876908, Publisher: Canadian Intellectual Property Office, Place of publication: Gatineau, Owner's name: MASARYKOVA UNIVERZITA, 2016
Other information
Language
English
Type of outcome
Patent
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Canada
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14310/16:00088400
Organization unit
Faculty of Science
Keywords in English
treatment; B-cell chronic lymphocytic leukemia; casein kinase 1
Změněno: 12/12/2016 15:25, Mgr. Eva Špillingová
Abstract
V originále
The invention provides new medicaments for the treatment of the B-cell chronic lymphocytic leukemia, which are inhibitors of casein kinase 1.
Links
GAP301/11/0747, research and development project |
| ||
MSM0021622430, plan (intention) |
| ||
NT11217, research and development project |
|